Rituximab-induced interstitial pneumonitis: report of two cases and literature review / 南方医科大学学报
Journal of Southern Medical University
; (12): 129-132, 2015.
Article
in Zh
| WPRIM
| ID: wpr-239221
Responsible library:
WPRO
ABSTRACT
We report two cases of rituximab (RTX)-induced interstitial pneumonia in two lymphoma patients receiving RTX treatment. Interstitial pneumonia was successfully managed in these two cases after a one-week-long intervention with corresponding treatments without affecting further treatment of the primary disease. RTX-induced interstitial pneumonia is characterized by a latent onset with an unclear pathological mechanism and absence of typical symptoms. High-resolution CT scan can provide valuable evidence for early diagnosis of RTX-induced interstitial pneumonia, which might be attributed partially to an increased susceptibility to P. jirovecii and fungal infection due to prolonged RTX treatment.
Full text:
1
Index:
WPRIM
Main subject:
Tomography, X-Ray Computed
/
Lung Diseases, Interstitial
/
Disease Susceptibility
/
Antibodies, Monoclonal, Murine-Derived
/
Rituximab
Type of study:
Screening_studies
Limits:
Humans
Language:
Zh
Journal:
Journal of Southern Medical University
Year:
2015
Type:
Article